Retrieved from Jain, A
Patients must be counseled for the potential risk for MTC with the use of Semaglutide and let them know about symptoms of thyroid tumors (e.g
Central appetite regulation The medication influences appetite centres in the brain to reduce hunger signals and increase satiety signals Enhanced post-meal satisfaction Patients typically report feeling satisfied with smaller portion sizes Clinical trials have demonstrated that patients taking semaglutide experience reductions in appetite and caloric intake
All ingredients:Odycea Onsen-Sui (Thermal water), Propanediol, Glycerin, Tranexamic Acid, Niacinamide, Panthenol, Chrysanthellum Indicum Extract, Ethylhexylglycerin, Tripeptide-1, Xanthan Gum, Allantoin, SH-Oligopeptide-1
Biohacker Protocol (experimental) Dose: 0.25 mg (= 10 clicks) Duration: Continuous Frequency: Twice daily Cycle Interval: No fixed interval / take 1 week off every 8 weeks Goal / Description: Micro-dosing approach focusing on steady fat metabolism